208 related articles for article (PubMed ID: 24403505)
41. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
42. Enolate-forming compounds provide protection from platinum neurotoxicity.
Geohagen BC; Weiser DA; Loeb DM; Nordstroem LU; LoPachin RM
Chem Biol Interact; 2020 Feb; 317():108961. PubMed ID: 31978392
[TBL] [Abstract][Full Text] [Related]
43. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
[No Abstract] [Full Text] [Related]
44. Drug-induced peripheral neuropathies.
Prescrire Int; 2013 Sep; 22(141):208-12. PubMed ID: 24171214
[No Abstract] [Full Text] [Related]
45. Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
Cavaletti G; Alberti P; Marmiroli P
Am Soc Clin Oncol Educ Book; 2015; ():e553-60. PubMed ID: 25993222
[TBL] [Abstract][Full Text] [Related]
46. [[Peripheral nervous system neurotoxicity secondary to chemotherapy treatment] ].
Iñiguez C; Larrodé P; Mayordomo JI; Mauri JA; Trés A; Morales F
Neurologia; 2000 Oct; 15(8):343-51. PubMed ID: 11143501
[TBL] [Abstract][Full Text] [Related]
47. [Platinum drugs].
Kusaba H; Baba E
Nihon Rinsho; 2015 Feb; 73 Suppl 2():143-5. PubMed ID: 25831739
[No Abstract] [Full Text] [Related]
48. Neurotoxicity of cancer chemotherapy.
Dropcho EJ
Semin Neurol; 2004 Dec; 24(4):419-26. PubMed ID: 15637653
[TBL] [Abstract][Full Text] [Related]
49. Oxaliplatin-related neurotoxicity: is chelation the solution?
Hoff PM
Nat Clin Pract Oncol; 2004 Dec; 1(2):78-9. PubMed ID: 16264824
[No Abstract] [Full Text] [Related]
50. [Neurologic side effects of cytotoxic drugs].
Lebrun C; Frenay M
Rev Med Interne; 2010 Apr; 31(4):295-304. PubMed ID: 20167398
[TBL] [Abstract][Full Text] [Related]
51. [Peripheral neuropathy induced by anticancer drugs].
Oishi R; Egashira N
Fukuoka Igaku Zasshi; 2013 May; 104(5):71-80. PubMed ID: 23885391
[No Abstract] [Full Text] [Related]
52. Protection of Bortezomib-induced Neurotoxicity by Antioxidants.
Iijima Y; Bandow K; Amano S; Sano M; Hino S; Kaneko T; Horie N; Sakagami H
Anticancer Res; 2020 Jul; 40(7):3685-3696. PubMed ID: 32620607
[TBL] [Abstract][Full Text] [Related]
53. d-Methionine protects against cisplatin-induced neurotoxicity in cortical networks.
Gopal KV; Wu C; Shrestha B; Campbell KC; Moore EJ; Gross GW
Neurotoxicol Teratol; 2012; 34(5):495-504. PubMed ID: 22732230
[TBL] [Abstract][Full Text] [Related]
54. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.
Joseph EK; Chen X; Bogen O; Levine JD
J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667
[TBL] [Abstract][Full Text] [Related]
55. Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
Meijer C; de Vries EG; Marmiroli P; Tredici G; Frattola L; Cavaletti G
Neurotoxicology; 1999 Dec; 20(6):883-7. PubMed ID: 10693969
[TBL] [Abstract][Full Text] [Related]
56. Platinum-drugs induced peripheral neurotoxicity: clinical course and preclinical evidence.
Alberti P
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):487-497. PubMed ID: 31116618
[No Abstract] [Full Text] [Related]
57. The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects?
Park SB; Lin CS; Krishnan AV; Kiernan MC
Cancer Chemother Pharmacol; 2011 May; 67(5):1189-90; author reply 1191-2. PubMed ID: 21327679
[No Abstract] [Full Text] [Related]
58. Chemotherapeutic neuropathy.
Windebank AJ
Curr Opin Neurol; 1999 Oct; 12(5):565-71. PubMed ID: 10590893
[TBL] [Abstract][Full Text] [Related]
59. Circulating nerve growth factor level changes during oxaliplatin treatment-induced neurotoxicity in the rat.
Cavaletti G; Petruccioli MG; Marmiroli P; Rigolio R; Galbiati S; Zoia C; Ferrarese C; Tagliabue E; Dolci C; Bayssas M; Griffon Etienne G; Tredici G
Anticancer Res; 2002; 22(6C):4199-204. PubMed ID: 12553056
[TBL] [Abstract][Full Text] [Related]
60. Neurotoxicity of antineoplastic drugs: Mechanisms, susceptibility, and neuroprotective strategies.
Pellacani C; Eleftheriou G
Adv Med Sci; 2020 Sep; 65(2):265-285. PubMed ID: 32361484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
